Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 20.13
(3.76%)
CNY 20.13
(3.76%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 141.84 Million CNY | 15.92% |
| 2022 | 132.91 Million CNY | 8.2% |
| 2021 | 122.84 Million CNY | 28.94% |
| 2020 | 95.26 Million CNY | -8.16% |
| 2019 | 103.73 Million CNY | 48.61% |
| 2018 | 69.8 Million CNY | 28.0% |
| 2017 | 54.53 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 41.77 Million CNY | 18.51% |
| 2024 Q3 | 39.62 Million CNY | -2.85% |
| 2024 Q1 | 35.25 Million CNY | -30.53% |
| 2023 Q3 | 29.83 Million CNY | -25.85% |
| 2023 FY | 154.07 Million CNY | 15.92% |
| 2023 Q4 | 50.74 Million CNY | 70.07% |
| 2023 Q2 | 40.23 Million CNY | 20.98% |
| 2023 Q1 | 33.25 Million CNY | 6.42% |
| 2022 Q3 | 37.17 Million CNY | 9.15% |
| 2022 Q2 | 34.06 Million CNY | 11.96% |
| 2022 Q1 | 30.42 Million CNY | -14.36% |
| 2022 FY | 132.91 Million CNY | 8.2% |
| 2022 Q4 | 31.25 Million CNY | -15.94% |
| 2021 Q1 | 27 Million CNY | 8.61% |
| 2021 Q4 | 35.52 Million CNY | 19.64% |
| 2021 FY | 122.84 Million CNY | 28.94% |
| 2021 Q3 | 29.69 Million CNY | -3.04% |
| 2021 Q2 | 30.62 Million CNY | 13.39% |
| 2020 Q3 | 29.18 Million CNY | 26.13% |
| 2020 Q1 | 18.07 Million CNY | -28.93% |
| 2020 Q2 | 23.14 Million CNY | 28.05% |
| 2020 FY | 95.26 Million CNY | -8.16% |
| 2020 Q4 | 24.86 Million CNY | -14.81% |
| 2019 FY | 103.73 Million CNY | 48.61% |
| 2019 Q3 | 29.82 Million CNY | 4.27% |
| 2019 Q2 | 28.6 Million CNY | 43.88% |
| 2019 Q1 | 19.87 Million CNY | 0.0% |
| 2019 Q4 | 25.42 Million CNY | -14.73% |
| 2018 FY | 69.8 Million CNY | 28.0% |
| 2017 FY | 54.53 Million CNY | 0.0% |